FDA Investigator Daniel L Obrzut
Daniel L Obrzut has inspections in 3 countries as of 01 Jun 2023. Daniel L Obrzut has collaborated with a combined 600 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
01 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Belgium,
United States of America,
India
Co-Investigator(s):
Andrew J Barrowcliff,
Azza Talaat,
Bei Y He,
Charles R Cote, RIC,
Christopher R Czajka,
Constantin Y Philopoulos,
Courtney E Hillier,
Dennis Cantellops Paite,
Dr. Jason R Caballero,
Emilie E Kahn,
Emily J Orban,
James C Maclaughlin,
Jeffrey D Meng,
Kathryn A Guardiola,
Kathryn G Brown,
Kellia N Hicks,
Lata C Mathew, PhD,
Lauren E Sexton,
Lisa J Joseph,
Marcus A Ray,
Martin R Vowell,
Michele L Forster, PhD,
Muralidhara B Gavini, PhD,
Nancy M Espinal,
Nina Ni,
Patsy J Domingo,
Rebecca E Dombrowski,
Ryan J Benedict,
Sanket N Patel,
Sarah E Rhoades,
Sarah M Meng,
Timothy T Kapsala,
Tracey L Harris
Daniel L Obrzut's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2018 | FDA 483 | RECIPHARM PHARMASERVICES PRIVATE LIMITED - Form 483, 2018-05-11 |
December, 2019 | FDA 483 | Future Pak LLC - Form 483, 2019-12-12 |
February, 2024 | FDA 483 | Lilly del Caribe, Inc. - Form 483, 2024-02-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more